{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:38:29Z","timestamp":1793367509619,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006380","name":"Universit\u00e4t f\u00fcr Bodenkultur Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEA_FF_68_003_3300_001"],"award-info":[{"award-number":["HEA_FF_68_003_3300_001"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.btre.2025.e00927","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:58:04Z","timestamp":1759305484000},"page":"e00927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice"],"prefix":"10.1016","volume":"48","author":[{"given":"Christine Joy I.","family":"Bulaon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janejira","family":"Jaratsittisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaewta","family":"Rattanapisit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pipob","family":"Suwanchaikasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khwanchit","family":"Boonha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannamthip","family":"Pitaksajjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipaporn","family":"Simsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vudhiporn","family":"Limprasutr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waranyoo","family":"Phoolcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.btre.2025.e00927_bib0001","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1080\/17425255.2016.1216976","article-title":"Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma","volume":"12","author":"Longoria","year":"2016","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.btre.2025.e00927_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejca.2020.02.016","article-title":"A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation","volume":"131","author":"Lala","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.btre.2025.e00927_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1167975","article-title":"Immune-related adverse events of immune checkpoint inhibitors: a review","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.btre.2025.e00927_bib0004","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-translational modifications in the context of therapeutic proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.btre.2025.e00927_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102402","article-title":"Fc-engineered therapeutic antibodies: recent advances and future directions","volume":"15","author":"Abdeldaim","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.btre.2025.e00927_bib0006","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/bit.20151","article-title":"Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity","volume":"87","author":"Yamane-Ohnuki","year":"2004","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.btre.2025.e00927_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biologicals.2016.02.003","article-title":"Effect of high mannose glycan pairing on IgG antibody clearance","volume":"44","author":"Liu","year":"2016","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.btre.2025.e00927_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nbt.1601","article-title":"Enhanced antibody half-life improves in vivo activity","volume":"28","author":"Zalevsky","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.btre.2025.e00927_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-61779-974-7_23","article-title":"Transient and stable expression of antibodies in Nicotiana species","volume":"907","author":"Garabagi","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.btre.2025.e00927_bib0010","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.3390\/ijms26125510","article-title":"Harnessing transient expression systems with plant viral vectors for the production of biopharmaceuticals in Nicotiana benthamiana","volume":"26","author":"Akher","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.btre.2025.e00927_bib0011","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2013594","article-title":"Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana","volume":"14","author":"Swope","year":"2022","journal-title":"MAbs"},{"issue":"12","key":"10.1016\/j.btre.2025.e00927_bib0012","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.btre.2025.e00927_bib0013","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/pbi.12981","article-title":"CRISPR\/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking \u03b2-1,2-xylose and core \u03b1-1,3-fucose","volume":"17","author":"Jansing","year":"2019","journal-title":"Plant Biotechnol. J."},{"issue":"11","key":"10.1016\/j.btre.2025.e00927_bib0014","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/pbi.13902","article-title":"Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant-made lectin-fc fusion protein","volume":"20","author":"Dent","year":"2022","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.btre.2025.e00927_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2018.00081","article-title":"Advanced plant-based glycan engineering","author":"Montero-Morales","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.btre.2025.e00927_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13238-017-0433-3","article-title":"Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy","volume":"9","author":"Mimura","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.btre.2025.e00927_bib0017","first-page":"1","article-title":"Integrative genomic and proteomic profiling for personalized oncological treatments: enhancing therapeutic efficacy and reducing adverse effects in breast cancer patients","volume":"2023","author":"SN","year":"2023","journal-title":"SHIFAA"},{"key":"10.1016\/j.btre.2025.e00927_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.70470\/SHIFAA\/2023\/004","article-title":"Design and synthesis of biodegradable polymeric nanoparticles for targeted delivery of chemotherapeutics in triple-negative breast cancer","volume":"2023","author":"Ahmed","year":"2023","journal-title":"SHIFAA"},{"issue":"4","key":"10.1016\/j.btre.2025.e00927_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","article-title":"Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure","volume":"6","author":"Strasser","year":"2008","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.btre.2025.e00927_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.736299","article-title":"Functional characterization of Pembrolizumab produced in Nicotiana benthamiana using a rapid Transient expression system","volume":"12","author":"Phakham","year":"2021","journal-title":"Front. Plant Sci."},{"issue":"3","key":"10.1016\/j.btre.2025.e00927_bib0021","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4161\/hv.7.3.14262","article-title":"Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants","volume":"7","author":"Chen","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.btre.2025.e00927_bib0022","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3389\/fpls.2018.01974","article-title":"Modifying the replication of geminiviral vectors reduces cell death and enhances expression of biopharmaceutical proteins in Nicotiana benthamiana leaves","volume":"9","author":"Diamos","year":"2018","journal-title":"Front. Plant Sci."},{"issue":"8","key":"10.1016\/j.btre.2025.e00927_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253574","article-title":"Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies","volume":"16","author":"Rattanapisit","year":"2021","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.btre.2025.e00927_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316790","article-title":"Plant-derived Pembrolizumab in conjugation with IL-15R\u03b1-IL-15 complex shows effective anti-tumor activity","volume":"20","author":"Rattanapisit","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.btre.2025.e00927_bib0025","article-title":"Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL\/6-hPD-1 mouse implanted with MC38 colon cancer","volume":"38","author":"Bulaon","year":"2023","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.btre.2025.e00927_bib0026","article-title":"The impact of N-glycans on the immune response of plant-produced SARS-CoV-2 RBD-fc proteins","volume":"43","author":"Srisangsung","year":"2024","journal-title":"Biotechnol. Rep."},{"issue":"7","key":"10.1016\/j.btre.2025.e00927_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/plants9070842","article-title":"Plant Molecular farming: a viable platform for recombinant biopharmaceutical production","volume":"9","author":"Shanmugaraj","year":"2020","journal-title":"Plants"},{"issue":"3","key":"10.1016\/j.btre.2025.e00927_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5511\/plantbiotechnology.21.0610a","article-title":"Transient protein expression systems in plants and their applications","volume":"38","author":"Nosaki","year":"2021","journal-title":"Plant Biotechnol."},{"key":"10.1016\/j.btre.2025.e00927_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.736299","article-title":"Functional characterization of Pembrolizumab produced in Nicotiana benthamiana using a rapid Transient expression system","author":"Phakham","year":"2021","journal-title":"Front. Plant Sci."},{"issue":"8","key":"10.1016\/j.btre.2025.e00927_bib0030","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/annonc\/mdx235","article-title":"Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg\/kg dosing regimen in patients with advanced tumors","volume":"28","author":"Zhao","year":"2017","journal-title":"Ann. oncol. : off. J. Eur. Soc. Med. Oncol."},{"issue":"17","key":"10.1016\/j.btre.2025.e00927_bib0031","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with Immune checkpoint inhibitor therapy: american Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.btre.2025.e00927_bib0032","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"13","key":"10.1016\/j.btre.2025.e00927_bib0033","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1073\/pnas.0832472100","article-title":"Function and glycosylation of plant-derived antiviral monoclonal antibody","volume":"100","author":"Ko","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"5","key":"10.1016\/j.btre.2025.e00927_bib0034","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-7652.2009.00497.x","article-title":"Plant-specific glycosylation patterns in the context of therapeutic protein production","volume":"8","author":"Gomord","year":"2010","journal-title":"Plant Biotechnol. J."},{"issue":"8\u20139","key":"10.1016\/j.btre.2025.e00927_bib0035","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.molimm.2009.01.026","article-title":"Dall'acqua WF. Structural characterization of a human Fc fragment engineered for extended serum half-life","volume":"46","author":"Oganesyan","year":"2009","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.btre.2025.e00927_bib0036","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.4049\/jimmunol.1401218","article-title":"Fc engineering of Human IgG1 for altered binding to the neonatal Fc receptor affects Fc effector functions","volume":"194","author":"Grevys","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.btre.2025.e00927_bib0037","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.crimmu.2020.06.001","article-title":"Impact of IgG1 N-glycosylation on their interaction with fc gamma receptors","volume":"1","author":"Cambay","year":"2020","journal-title":"Curr. Res. Immunol."},{"issue":"7520","key":"10.1016\/j.btre.2025.e00927_bib0038","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.btre.2025.e00927_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058724","article-title":"Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems","volume":"8","author":"Rosenberg","year":"2013","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.btre.2025.e00927_bib0040","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (Keytruda)","volume":"12","author":"Kwok","year":"2016","journal-title":"Hum. Vaccin. ImmunOther"},{"key":"10.1016\/j.btre.2025.e00927_bib0041","author":"Dammen-Brower","year":"2022","journal-title":"Strateg. Glycoengineering Ther. Proteins"},{"key":"10.1016\/j.btre.2025.e00927_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114796","article-title":"Multi-approach LC-MS methods for the characterization of species-specific attributes of monoclonal antibodies from plants","volume":"216","author":"Tengattini","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.btre.2025.e00927_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143520","article-title":"Multi-angle effector function analysis of Human monoclonal IgG glycovariants","volume":"10","author":"Dashivets","year":"2015","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.btre.2025.e00927_bib0044","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.btre.2025.e00927_bib0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1208\/s12248-014-9694-4","article-title":"Impact of glycation on antibody clearance","volume":"17","author":"Yang","year":"2015","journal-title":"AAPS. J."}],"updated-by":[{"DOI":"10.1016\/j.btre.2026.e00986","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:00:00Z","timestamp":1793318400000}}],"container-title":["Biotechnology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X25000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X25000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:55:11Z","timestamp":1791820511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215017X25000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":45,"alternative-id":["S2215017X25000542"],"URL":"https:\/\/doi.org\/10.1016\/j.btre.2025.e00927","relation":{},"ISSN":["2215-017X"],"issn-type":[{"value":"2215-017X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.btre.2025.e00927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00927"}}